CHEN BIHUA purchased 9.5% of their position (312.50K shares) of BLOSSOMHILL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.00M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+1.60M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.70M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+312.50K
Price / share
$16.00
Trade value
$5M
% of position
Net shares
+3.61M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2026 | C · Conversion | +1.60M | — | — | New position | 0.00 | 1.60M |
| Common Stock Indirect | 8/10/2026 | C · Conversion | +1.70M | — | — | 106.3% | 1.60M | 3.30M |
| Common Stock Indirect | 8/10/2026 | P · Purchase | +312.50K | $16.00 | $5M | 9.5% | 3.30M | 3.61M |
| Total | +3.61M | $5M | ||||||
Director Stock Option (Right to Buy)
Common Stock
23.90K shares
Shares
+23.90K
Strike price
16
Held after
23.90K
Exercisable
—
Series A Preferred Stock
Common Stock
1.60M shares
Shares
−1.60M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.70M shares
Shares
−1.70M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) Direct | Common Stock23.90K shares | 8/6/2026 | A · Award | +23.90K | 16 | — | 23.90K |
| Series A Preferred Stock Indirect | Common Stock1.60M shares | 8/10/2026 | C · Conversion | −1.60M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.70M shares | 8/10/2026 | C · Conversion | −1.70M | — | 0.00 |